Tizona Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Tizona Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers (NCT04485013) | Tizona Therapeutics, Inc | 2020-07-14 |
Track Tizona Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.